MedChunk
Medically reviewed

AMH Levels for IVF: Is There a Target? Results Explained

Learn what AMH levels mean for IVF, whether there is an ideal target, how low and high results affect ovarian response, and what they can tell you about treatment outcomes.

By Caleb Bennett Reviewed by Dr. Irene Medical review dateNov 19, 2026 14 min read

There is no single ideal AMH level that guarantees success with IVF. Anti-Müllerian hormone (AMH) helps estimate how many eggs the ovaries may produce in response to fertility medication, but it cannot reliably predict egg quality, pregnancy, or live birth. Fertility specialists interpret the result alongside age, ultrasound findings, medical history, and other fertility test results.

What Does AMH Measure Before IVF?

AMH is a hormone produced by cells in small developing follicles in the ovaries. These follicles contain immature eggs. Measuring AMH in the blood gives doctors an estimate of ovarian reserve, which refers mainly to the quantity of eggs remaining in the ovaries.

During IVF, fertility medications are used to encourage several ovarian follicles to develop at the same time. The eggs are then collected for fertilization in the laboratory. AMH helps the fertility specialist estimate how the ovaries might respond to these medications.

According to MedlinePlus, AMH testing can help estimate ovarian reserve and predict the likely response to fertility medication. However, the test cannot determine the health of the eggs or establish whether someone will become pregnant.

This distinction is important because having more eggs available does not automatically mean having better-quality eggs or a higher chance of having a baby.

Is There an Ideal AMH Level for IVF?

No universally accepted AMH target applies to everyone undergoing IVF. A result that suggests an appropriate ovarian response in one person may have a different meaning in another, depending on age, the laboratory method, and other clinical findings.

Rather than trying to achieve a particular AMH number, fertility specialists use the test to estimate whether the ovaries are likely to have a low, expected, or high response to stimulation medication.

The American Society for Reproductive Medicine (ASRM) explains that AMH and antral follicle count are useful for predicting the number of eggs that may be collected during IVF. However, they are much less reliable as independent predictors of pregnancy and live birth.

Therefore, an AMH result should be viewed as a treatment-planning tool rather than a score that determines whether IVF will work.

How Are Low, Normal, and High AMH Levels Interpreted for IVF?

AMH results are usually reported in nanograms per millilitre (ng/mL) or picomoles per litre (pmol/L). The laboratory report may include a reference range, but this range is not necessarily an ideal IVF target.

Laboratories may use different testing methods, and fertility clinics may use different thresholds when estimating ovarian response. For this reason, the interpretation should consider the laboratory's reference information and the person's overall fertility assessment.

Low AMH: What Does It Mean for IVF?

A low AMH result may suggest diminished ovarian reserve, meaning that fewer eggs are available in the developing follicle pool.

During IVF, this may be associated with a lower response to stimulation medication and fewer eggs collected during retrieval. The specialist may discuss the possibility of obtaining fewer eggs or needing more than one treatment cycle, depending on the complete clinical picture.

However, low AMH does not mean that IVF cannot succeed. It also does not mean that there are no eggs available.

The ASRM committee opinion on ovarian reserve testing specifically states that even extremely low AMH values should not be used by themselves to refuse IVF treatment. Such results can help patients understand the possibility of a lower egg yield, but they do not establish that pregnancy is impossible.

A fertility specialist may consider several factors when planning treatment with a low AMH result:

  • Age: Age helps provide information about expected egg quality and the likelihood of reproductive success.
  • Antral follicle count: An ultrasound examination helps estimate the number of small follicles visible in the ovaries.
  • Previous IVF response: If IVF has been attempted before, the number of follicles developed and eggs collected provides useful information.
  • Other fertility findings: Medical history and relevant reproductive investigations help guide the treatment plan.

Normal AMH: Does It Mean IVF Will Be Successful?

An AMH result within the laboratory's expected range may suggest that the ovaries have a reasonable supply of developing follicles. It can also help the fertility specialist estimate the likely response to stimulation medication.

However, a normal result does not guarantee that enough eggs will mature, that fertilization will occur, or that a healthy embryo will develop.

For example, a younger person and an older person may have similar AMH results but different chances of achieving a live birth. This is partly because AMH mainly reflects egg quantity, whereas age is an important factor in egg quality.

According to Cleveland Clinic, AMH provides information about ovarian reserve and may help predict the response to injectable fertility medication, but it does not independently predict fertility.

High AMH: Is a Higher Result Better for IVF?

A high AMH result may indicate a larger pool of developing follicles. This can mean that the ovaries are likely to respond strongly to fertility medication and may produce a higher number of eggs during IVF.

However, a higher number is not always an advantage. A strong ovarian response can increase the risk of ovarian hyperstimulation syndrome (OHSS), a complication in which the ovaries become enlarged and fluid can accumulate in the body.

High AMH can also be seen in people with polycystic ovary syndrome (PCOS), although an elevated AMH result alone does not establish that diagnosis.

The ASRM guideline on preventing ovarian hyperstimulation syndrome identifies elevated AMH as one of the factors associated with an increased risk of OHSS. It recommends individualized stimulation planning and appropriate prevention strategies for people at higher risk.

Therefore, a high AMH result does not necessarily mean better IVF outcomes. It may instead indicate that the fertility team needs to plan medication and monitoring carefully.

How Does Age Change the Meaning of AMH Results?

Age is one of the most important factors when interpreting AMH results for IVF. AMH generally decreases as a person gets older because the number of remaining eggs declines over time.

However, two people of the same age can have different AMH levels. Similarly, two people with the same AMH level can have different reproductive prospects because their egg quality and other fertility factors may differ.

Consider these examples:

  • A younger person with low AMH: The result may indicate fewer available eggs than expected for that age, but the remaining eggs may still have reproductive potential.
  • An older person with normal AMH: The result may suggest an adequate follicle supply, but it cannot reverse the age-related changes that affect egg quality.
  • A person with high AMH: A larger follicle pool may support a stronger response to stimulation, but it does not guarantee better embryo development or pregnancy.

This is why fertility specialists do not interpret AMH using one universal age-independent target. Age, ovarian reserve, previous treatment response, and the broader reproductive history all contribute to treatment planning.

How Does AMH Help Doctors Plan IVF Medication?

One of the main reasons to measure AMH before IVF is to estimate how the ovaries may respond to gonadotropins, which are injectable hormones used to stimulate follicle development.

The fertility specialist uses this information to choose a suitable starting dose and stimulation approach. The aim is to encourage an appropriate number of follicles to develop while avoiding an excessively weak or strong response.

AMH does not determine the medication dose by itself. Other information, particularly ultrasound findings and previous treatment results, can affect the decision.

When AMH Is Low

A low AMH result may lead the specialist to discuss the possibility of a lower egg yield. The stimulation plan is individualized according to the person's age, ovarian reserve, and previous response, if available.

Using a higher medication dose does not necessarily overcome a limited follicle supply. The purpose of treatment planning is to use an appropriate approach rather than simply increase the amount of medication.

When AMH Is High

A high AMH result may indicate that the ovaries could respond strongly to stimulation. The fertility specialist may consider a more cautious starting medication dose and a treatment protocol designed to reduce OHSS risk.

Depending on the response during treatment, the team may also consider different approaches to triggering egg maturation and the timing of embryo transfer. These decisions are based on the developing follicles, hormone levels, and individual risk factors, rather than the AMH result alone.

AMH and Egg Quality: Why the Difference Matters

AMH mainly provides information about the quantity of eggs available in the ovarian follicle pool. It does not directly measure egg quality, which refers to the ability of an egg to develop into an embryo capable of producing a healthy pregnancy.

Egg quality is particularly important because not every collected egg will be mature, fertilized, or develop into an embryo suitable for transfer.

Age is an important factor in egg quality and reproductive outcomes. A person with relatively low AMH at a younger age may have a different outlook from someone with the same AMH level at an older age.

ASRM's guidance on ovarian reserve testing emphasizes that ovarian reserve markers are better at predicting egg quantity and ovarian response than predicting pregnancy or live birth. Other factors, including age, sperm quality, embryo development, and laboratory techniques, also contribute to IVF outcomes.

What Other Tests Are Considered Alongside AMH?

AMH is useful, but it is only one part of an IVF assessment. Fertility specialists may use additional tests to understand ovarian reserve and plan stimulation more accurately.

Antral Follicle Count (AFC)

Antral follicle count is measured using a transvaginal ultrasound. The specialist counts the small follicles visible in both ovaries, generally during the early part of the menstrual cycle.

AFC provides another estimate of the developing follicle pool and can help predict the ovarian response to IVF medication. It is often considered alongside AMH because both tests provide information about ovarian reserve.

Follicle-Stimulating Hormone (FSH)

FSH is a hormone produced by the pituitary gland that helps stimulate follicle development. It is generally measured early in the menstrual cycle when used as part of an ovarian reserve assessment.

FSH may provide additional information in certain situations, especially when interpreted with estradiol. However, AMH and AFC are generally more useful for estimating ovarian response to IVF stimulation.

Medical and Treatment History

Doctors also consider previous fertility treatment, menstrual history, reproductive conditions, and other findings that may affect ovarian function. For someone who has already undergone IVF, the actual response to previous stimulation can be especially informative.

The American Society for Reproductive Medicine explains that AMH and AFC should support clinical judgment rather than replace an overall assessment of reproductive health.

Can AMH Levels Be Increased Before IVF?

AMH is a marker of ovarian reserve, not a hormone that can be reliably increased to restore the number of eggs remaining in the ovaries.

Some supplements, lifestyle changes, and hormonal treatments are promoted as ways to improve AMH. However, an increase in the measured AMH level does not necessarily mean that ovarian reserve has improved, that egg quality has increased, or that IVF success is more likely.

There is no established AMH target that patients need to reach before starting IVF. Delaying fertility treatment solely to try to raise the AMH number may not be helpful, particularly when age and reproductive plans are important considerations.

Anyone considering supplements or hormonal treatment before IVF should discuss the proposed approach with their fertility specialist rather than starting products based on an AMH result alone.

When Should You Discuss Your AMH Result With a Fertility Specialist?

Discussing an AMH result with a reproductive medicine specialist is useful before making decisions about IVF, particularly when the result is outside the laboratory's expected range.

It is helpful to bring the complete laboratory report rather than relying only on a number from an online calculator or a previous test. The report's units, laboratory reference range, and testing method can affect interpretation.

During the consultation, useful questions include:

  • What does my AMH result suggest about my expected ovarian response?
  • How does my age affect the interpretation of this result?
  • Does my ultrasound antral follicle count agree with my AMH level?
  • What number of eggs might reasonably be expected during stimulation?
  • Does my result suggest a higher risk of ovarian hyperstimulation syndrome?
  • How might this information influence my IVF medication and treatment plan?

These discussions can help set realistic expectations about egg collection and the possible steps involved in treatment.

What Is the Most Important Thing to Remember About AMH and IVF?

AMH is valuable because it helps fertility specialists estimate how the ovaries may respond to stimulation medication. It is not a direct measure of egg quality and cannot determine whether IVF will result in pregnancy or a live birth.

A low result does not automatically rule out IVF, while a high result does not guarantee better outcomes. The most useful interpretation combines AMH with age, antral follicle count, medical history, and previous treatment response. Instead of focusing on a particular target number, the goal is to develop an individualized IVF plan that considers both treatment effectiveness and safety.

Frequently Asked Questions

Common questions about AMH results, ovarian reserve, and the likelihood of success with IVF.

What AMH level is considered good for IVF?

There is no universally accepted AMH level that is considered best for IVF. AMH is used mainly to estimate ovarian response and possible egg yield. A result should be interpreted according to age, laboratory reference ranges, ultrasound findings, and other fertility information.

Can IVF be successful with very low AMH?

Yes, IVF can sometimes be successful even when AMH is very low. Low AMH may indicate that fewer eggs will be collected, but it does not mean that pregnancy is impossible. Age, egg quality, embryo development, and other fertility factors also influence the outcome.

Does high AMH increase the chances of IVF pregnancy?

Not necessarily. High AMH may indicate a larger pool of developing follicles and a stronger response to stimulation medication. However, it does not guarantee better egg quality, embryo development, or pregnancy. Higher AMH may also be associated with an increased risk of ovarian hyperstimulation syndrome.

Should AMH be tested on a particular day of the menstrual cycle before IVF?

AMH can generally be measured at any point during the menstrual cycle because its levels are relatively stable compared with some other reproductive hormones. Your fertility clinic can advise when to have the test as part of your overall assessment.

Does low AMH mean I need donor eggs for IVF?

No. Low AMH alone does not mean that donor eggs are necessary. The decision depends on several factors, including age, previous IVF response, egg and embryo development, and individual reproductive circumstances. A fertility specialist can explain the available options based on the complete assessment.

Citations

  1. American Society for Reproductive Medicine (ASRM) – Testing and Interpreting Measures of Ovarian Reserve: A Committee Opinion
  2. MedlinePlus – Anti-Müllerian Hormone Test
  3. Cleveland Clinic – Anti-Mullerian Hormone Test: Purpose, Levels and Results
  4. ReproductiveFacts.org – Ovarian Reserve: Predicting Fertility Potential in Women
  5. American Society for Reproductive Medicine (ASRM) – Prevention of Moderate and Severe Ovarian Hyperstimulation Syndrome: A Guideline
Share this article